Nomura Holdings’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.98M | Sell |
177,300
-397,600
| -69% | -$10.6M | 0.01% | 637 |
|
|
2025
Q4 | $14.3M | Buy |
574,900
+279,000
| +94% | +$7.04M | 0.02% | 415 |
|
|
2025
Q3 | $7.54M | Buy |
295,900
+148,800
| +101% | +$3.67M | 0.01% | 618 |
|
|
2025
Q2 | $3.57M | Sell |
147,100
-1,408,200
| -91% | -$32.8M | 0.01% | 667 |
|
|
2025
Q1 | $39.4M | Buy |
+1,555,300
| New | +$40.7M | 0.07% | 175 |
|
|
2024
Q3 | – | Sell |
-9,600
| Closed | -$269K | – | 1893 |
|
|
2024
Q2 | $269K | Buy |
+9,600
| New | +$264K | ﹤0.01% | 1500 |
|
|
2024
Q1 | – | Sell |
-1,782,500
| Closed | -$51.3M | – | 1929 |
|
|
2023
Q4 | $51.3M | Buy |
1,782,500
+888,400
| +99% | +$26.9M | 0.14% | 124 |
|
|
2023
Q3 | $29.7M | Sell |
894,100
-470,000
| -34% | -$16.6M | 0.08% | 160 |
|
|
2023
Q2 | $50M | Buy |
+1,364,100
| New | +$53.1M | 0.14% | 121 |
|
|
2023
Q1 | – | Sell |
-700,000
| Closed | -$35.8M | – | 1662 |
|
|
2022
Q4 | $35.8M | Buy |
+700,000
| New | +$33.6M | 0.15% | 130 |
|
|
2022
Q3 | – | Sell |
-48,200
| Closed | -$2.49M | – | 1909 |
|
|
2022
Q2 | $2.49M | Sell |
48,200
-64,100
| -57% | -$3.27M | 0.01% | 738 |
|
|
2022
Q1 | $5.82M | Sell |
112,300
-605,500
| -84% | -$31.4M | 0.02% | 565 |
|
|
2021
Q4 | $42M | Buy |
717,800
+700,000
| +3,933% | +$34.7M | 0.11% | 137 |
|
|
2021
Q3 | $768K | Hold |
17,800
| – | – | ﹤0.01% | 1221 |
|
|
2021
Q2 | $697K | Hold |
17,800
| – | – | ﹤0.01% | 1206 |
|
|
2021
Q1 | $644K | Buy |
+17,800
| New | +$632K | ﹤0.01% | 1265 |
|
|
2020
Q3 | – | Sell |
-212,908
| Closed | -$6.61M | – | 1411 |
|
|
2020
Q2 | $6.61M | Buy |
212,908
+107,508
| +102% | +$3.65M | 0.02% | 333 |
|
|
2020
Q1 | $3.24M | Sell |
105,400
-52,700
| -33% | -$1.8M | 0.01% | 384 |
|
|
2019
Q4 | $5.85M | Sell |
158,100
-347,715
| -69% | -$12.4M | 0.02% | 411 |
|
|
2019
Q3 | $17M | Buy |
505,815
+356,252
| +238% | +$13M | 0.06% | 223 |
|
|
2019
Q2 | $6.18M | Buy |
+149,563
| New | +$5.94M | 0.03% | 425 |
|
|
2018
Q1 | – | Sell |
-423,603
| Closed | -$14.5M | – | 1625 |
|
|
2017
Q4 | $14.5M | Sell |
423,603
-879,457
| -67% | -$30M | 0.03% | 371 |
|
|
2017
Q3 | $44.1M | Buy |
1,303,060
+22,450
| +2% | +$722K | 0.09% | 126 |
|
|
2017
Q2 | $40.6M | Sell |
1,280,610
-2,427,994
| -65% | -$76.6M | 0.1% | 118 |
|
|
2017
Q1 | $120M | Sell |
3,708,604
-1,851,141
| -33% | -$58.4M | 0.31% | 36 |
|
|
2016
Q4 | $172M | Buy |
5,559,745
+1,491,200
| +37% | +$45.5M | 0.44% | 36 |
|
|
2016
Q3 | $131M | Sell |
4,068,545
-1,412,887
| -26% | -$47.2M | 0.37% | 43 |
|
|
2016
Q2 | $182M | Sell |
5,481,432
-3,780,909
| -41% | -$121M | 0.59% | 25 |
|
|
2016
Q1 | $262M | Buy |
9,262,341
+7,854,197
| +558% | +$224M | 0.88% | 15 |
|
|
2015
Q4 | $43.1M | Buy |
1,408,144
+881,144
| +167% | +$27.7M | 0.12% | 82 |
|
|
2015
Q3 | $15.7M | Buy |
+527,000
| New | +$16.9M | 0.06% | 170 |
|
|
2015
Q2 | – | Sell |
-330,956
| Closed | -$10.8M | – | 1975 |
|
|
2015
Q1 | $10.8M | Buy |
330,956
+105,295
| +47% | +$3.35M | 0.04% | 219 |
|
|
2014
Q4 | $6.65M | Sell |
225,661
-71,251
| -24% | -$2.04M | 0.02% | 501 |
|
|
2014
Q3 | $8.35M | Sell |
296,912
-1,707,796
| -85% | -$47.9M | 0.02% | 491 |
|
|
2014
Q2 | $56.3M | Buy |
2,004,708
+1,851,562
| +1,209% | +$52.8M | 0.02% | 136 |
|
|
2014
Q1 | $4.65M | Buy |
+153,146
| New | +$4.57M | ﹤0.01% | 779 |
|
Other funds holding PFE
VCM
VPM
Nomura Holdings's PFE Position: Q1 2026 in Review
Nomura Holdings reduced its Pfizer (PFE) stake by 49% in Q1 2026, selling an estimated $4.11M and leaving 157,700 shares worth $4.43M. The position accounts for 0.01% of the portfolio, ranked #679.
Nomura Holdings first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $61.3M in Q3 2017. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Nomura Holdings held 157,700 shares of Pfizer worth $4.43M as of Q1 2026.
- Nomura Holdings sold 154,473 Pfizer shares in Q1 2026, an estimated $4.11M.
- Pfizer made up 0.01% of Nomura Holdings's portfolio in Q1 2026, its #679 holding.
- Nomura Holdings first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Nomura Holdings's Pfizer position peaked at $61.3M in Q3 2017.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.